We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

NAUSEA MEDICINE MARKET ANALYSIS

Nausea Medicine Market, By Drug Class (Antihistamines, Anticholinergics, Serotonin Antagonists, Dopamine Antagonists, Cannabinoids, and Others), By Route of Administration (Oral, Injectable, Transdermal, Rectal, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI6064
  • Pages :150
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Nausea Medicine MarketSize and Trends

Global nausea medicine market is expected to grow from US$ 2.8 Bn in 2023 to US$ 4.3 Bn by 2030, at a CAGR of 6.3% during the forecast period 2023-2030.

Nausea and vomiting are common symptoms that are caused by a variety of conditions, including motion sickness, pregnancy, chemotherapy, and infections. The increasing prevalence of these conditions is driving the demand for nausea medicines.

  • Increasing prevalence of nausea: Nausea is a common symptom which is associated with various medical conditions, such as chemotherapy-induced nausea and vomiting (CINV), postoperative nausea and vomiting (PONV), motion sickness, and pregnancy-related nausea. The growing prevalence of these conditions creates a high demand for effective nausea medicines. For instance, on March 2023, according to the Pharmaceutical Journal, 90% of individuals will have motion sickness at some time in their life. However, the frequency and occurrence of this condition might differ greatly, based on several factors including age and gender, individual sensitivity, and transportation method.
  • Advancements in drug formulations: Pharmaceutical companies are continuously investing in research and development (R&D) to develop improved formulations of nausea medicines. The introduction of new drug delivery systems, such as oral dissolvable tablets, transdermal patches, and fast-acting injectables, has enhanced patient compliance and convenience, thus driving the market growth.
  • Increasing geriatric population: The elderly population is more susceptible to nausea due to various factors such as medication side effects, comorbidities, and age-related physiological changes. As the global population continues to age, the demand for nausea medicines among the geriatric population is expected to rise, thus driving the market growth.
  • Growing awareness and diagnosis: Increased awareness of nausea as a symptom and its impact on quality of life has led to a higher number of patients seeking medical attention and diagnosis. As a result, healthcare professionals are prescribing more nausea medicines, thereby driving the market growth. For instance, in July 2023, International Foundation for Gastrointestinal Disorders (IFFGD) announced awareness for Gastroparesis Awareness Month to shed light on the varied impact on the quality of life for individuals. Gastroparesis (GP) is a condition of slowed stomach emptying with no intestinal blockage with the most common symptom including nausea and vomiting.

Global Nausea Medicine Market Trends

  • Increasing focus on patient-centric approaches: There is a growing emphasis on patient-centric approaches in healthcare, including the management of nausea. The focus is shifting towards understanding patient preferences, needs, and experiences to develop tailored treatment options. This trend promotes shared decision-making, patient engagement, and personalized care in nausea medicine.
  • Integration of digital health solutions: The integration of digital health solutions, such as mobile applications, wearable devices, and remote monitoring tools, is gaining momentum in the nausea medicine market. These technologies offer opportunities for symptom tracking, medication reminders, and real-time communication with healthcare providers, thus enhancing patient adherence and improving outcomes. For instance, in August 2021, Reliefband, a company that develops wearable technology to prevent and treat symptoms of nausea and vomiting, launched Reliefband Sport, a new waterproof wearable therapeutic device that is IPX7 certified. In addition to treating post-operative nausea, Reliefband Sport also prevents and relieves nausea and vomiting that is related to motion sickness, pregnant morning sickness, anxiety, hangovers, headaches diagnosed by a doctor, and chemotherapy.
  • Rise in natural and herbal remedies: Increasingly, individuals are seeking natural and herbal remedies for managing nausea. This trend is driven by a desire for alternative therapies and a preference for more natural products. As a result, there is a growing market for natural antiemetic remedies, including herbal supplements and essential oils.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.